Terrance McGuire
Board Member
Tectonic Therapeutic, Inc. (TECX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Terrance McGuire
Terrance McGuire is recorded as Board Member at Tectonic Therapeutic, Inc. (TECX). Tectonic Therapeutic, Inc. reported in an 8-K filed February 24, 2026 that Terrance McGuire resigned as Chair of the Board, effective April 1, 2026. Tectonic Therapeutic, Inc. reported in an 8-K filed June 20, 2024 that Terrance McGuire was appointed member of the board of directors, effective June 20, 2024.
“Terrance McGuire notified the Board of his intent to (i) resign as Chair of the Board, effective as of April 1, 2026 (the "Effective Date") and (ii) resign from the Board, including its committees, effective as of the Company's 2026 annual stockholder meeting (the "2026 Annual Meeting").”
“Effective upon the closing of the Merger on June 20, 2024, the size of the board of directors was fixed at six members and the board of directors of the Company was reconstituted as follows: (i) Phillip B. Donenberg (designated by AVROBIO), and (ii) Alise Reicin, M.D., Terrance McGuire, Timothy A. Springer, Ph.D., Praveen Tipirneni, M.D. and Stefan Vitorovic, M.S., M.B.A. (designated by Tectonic).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-20–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tectonic Therapeutic, Inc.
Other people whose current roles at this company are on record from its filings.
- Alise Reicin CEO, Board Member
- Alise Reicin, M.D. CEO, Board Member
- Erik Ostrowski CEO
- François Nader Chairman, Board Member
- Daniel Lochner CFO
- Christian Cortis COO
- Christian Cortis, Ph.D. COO
- Azadeh Golipour CTO
- Peter McNamara CTO
- Peter McNamara, Ph.D. CTO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.